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Review
In 2009, the Working Party on Rare Donors of the German 
Society of Transfusion Medicine and Immunohematology 
(DGTI), which represents the German-speaking countries 
of Switzerland, Germany, and Austria (Fig. 1), started to 
develop a joint database for rare donors. The database was 
implemented in 2011 in Berne, Switzerland, and is maintained 
by the Swiss Red Cross Blood Service (public access: http://
www.iblutspende.ch/en/rare-donors/rare-donors.html).
Germany and Switzerland, which have mostly Caucasian 
populations, started rare donor programs in the 1990s 
(Table 1), focusing on donors negative for Kpb, Vel, Lub, and 
Yta. In 2003, Seltsam et al.1 conducted a survey for patients 
with antibodies against high-prevalence antigens in the 
major reference laboratories and blood services in Germany, 
Switzerland, and Austria. During the 20-month observation 
period, 56 cases were reported. In 71 percent of these cases, 
antibodies against Kpb, Vel, Lub, Yta, or Coa were detected, 
confirming the direction of the early programs. In recent 
years, high-throughput molecular methods were developed 
and implemented. These methods have made it possible to 
test donors for high-frequency alleles independent of the 
availability of specific antisera, which often were not available 
in appropriate quantity and quality. At present, about 1100 
donors with rare blood types are listed in the DGTI database 
(Table 2). Most of these donors are registered by the Swiss 
Blood Services. The listing of German and Austrian donors 
has not yet been completed.
In order to keep blood donation on a volunteer basis, no 
incentives are offered for rare donors.
In 2012, Switzerland imported four red blood cell (RBC) 
units with the Lu(b–) phenotype and exported two RBC units 
with the Jk(a–b–) phenotype. Seventeen rare blood units [1 
Lu(b–), 3 K+k–, 5 Yt(a–), 8 Vel–] were shipped within the 
country. According to the German authorities no RBC units 
were imported in 2012. Germany exported 302 units to 
European countries, although the number of rare phenotypes 
included was not specified. From 2012 to 2014, 136 (37 
cryopreserved) units were shipped domestically [44 Lu(b–), 
71 Yt(a–), 3 Vel–, 9 AnWj–, 4 Co(a–), 1 Kp(b–), 2 PP1Pk–, 
1 RzRz (CCD.EE), 1 GE:–2]. Requests for rare phenotypes are 
not systematically documented by most blood services, thus 
no exact data are provided for unfilled requests.
Neither in Germany nor in Switzerland were intentionally 
incompatible transfusions reported in the case where a request 
for rare units could not be filled. It is likely that other measures, 
such as administration of erythropoietin or inclusion in an 
autologous blood program, were taken. This information, 
however, is scarce and laboratories normally cannot track 
these cases.
There is one known donor with the Rhnull phenotype in 
Switzerland. This donor carries the allele RHAG*01N.02. 
In Germany, one donor with Rhnull and one with the Rhmod 
Fig. 1. Blood service centers in Austria, Germany, and Switzerland 
that reported rare donor screening programs. Centers (noted with 











64 IMMUNOHEMATOLOGY, Volume 32, Number 2, 2016
H. Hustinx et al.




donors tested Method of testing
Rare donor screening/number of donors identified
Lu(b–) Kp(b–) Yt(a–) Co(a–) LU:–14 Vel– MAR– Fy(a–b–) S–s– U– Lan– K0
Austrian Red Cross Blood Center, Vienna, Austria — C. Jungbauer et al. 2007–2015* 25,000 Molecular X X X X X – – – – – – 30 additional alleles are tested
20 2 68 31 8 – – – – – –
Interregional Blood Transfusion SRC Ltd., Berne, Switzerland — H. Hustinx et al. 2010–2011 52,000 Serologic – X – – – – – – – – – Additional antigens were tested
2011–2012 40,000 Serologic – – – – – X – – – – –
2013 35,000 Serologic – – – – – – X – – – –
2011–2015† 21,000 Molecular X X X X – X – – – – – 22 additional alleles are tested
35 10 60 46 – 13 – – – – –
Red Cross Blood Service, Institute, Zurich, Switzerland — B. Frey et al. 2012–2015‡ 40,000 Molecular X X X X X X – – – – – Additional alleles are tested
44 6 86 28 7 3 – – – – –
Red Cross Blood Service West Institute, Hagen, Germany — B. Just et al. 1996–1998 22,000 Serologic – – – – – X – – – – –
2004–2005 2000 Serologic – – X – – – – – – –
2008–2009 5600 Serologic X X X X X – – – – –
2009–today§ >250 Serologic – – – – – – – X X – –
8 3 19 11 – 17 – 62 3 – –
2012–today¶ >4000 Molecular X X X X – X – – – – – Additional alleles are tested
5 0 9 12 – 0 – – – – –
Bavarian Red Cross Blood Service Institute, Munich, Germany — J. Burkhart et al. 1999–2000 5500 Serologic X X – – – – – – – –
1999–2000 5000 Serologic – X – – – – – – – X –
1999–2000 5000 Serologic – – – – – X – – – – X
5 0 14 – – 0 – – – 1 0
Red Cross Blood Service NSTOB Institute, Springe, Germany — F.F. Wagner et al. 2005–2007# 3400 Molecular X X X X – – – – – – –
2007–2013** 64,000 Molecular X X X X – – – – – – –
2013–today** >22,000 Molecular X X X – – X – – – – –
209 11 190 146 – 12 – – – – –
Red Cross Blood Service Baden-Württemberg, Hessen Institute, Baden-Baden, Germany — 
E.A. Scharberg et al.
1998–2012 15,000 Serologic X X – – – – – – – – –
2013–2014 35,000 Serologic X X – – – X – X – – –
2013–2014 150,000 Serologic – – – – X – – – –
12 1 – – – 5 8 3 – – –
Red Cross Blood Service Baden-Württemberg, Hessen Institute Ulm, Ulm, Germany —  
I. von Zabern et al.
2009–2010# 2500 Molecular X X X X – – – – – – –
2 0 13 3 – – – – – – –
*Six multiplex polymerase chain reactions (5–7 primer pairs) for a single blood donor2; agarose gel electrophoresis.
†In-house method.
‡Matrix-assisted laser desorption/ionization, time-of-flight (MALDI-TOF).3
§Only donors of African or Asian origin are included.
¶MALDI-TOF; testing for VEL*01N/01N was added in 2014.
#Manual testing using agarose gels.4
** Semi-automated testing using pooled capillary electrophoresis; CO switched to VEL in August 2013.
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phenotype are known. The molecular background of the Rhnull 
donor is under investigation. The Rhmod phenotype is caused 
by heterozygosity for the RHAG*01N.03 allele and a new allele 
with a single nucleotide polymorphism causing an amino 
acid substitution located at the transmembrane/intracellular 
border. This donor carries Rh antigens at a very low level that 
can be detected by absorption and elution methods only.
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Table 2. Rare donors listed in the German Society for Transfusion 
Medicine and Immunohematology (DGTI) database as of 2015
























Pk (P–; GLOB:–1) 1
Rhnull 1
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